Selecting The Best Treatment Option For A Dog With Cushing’S Syndrome

1. Galac S, Reusch C, Kooistra H, Rijnberk A. Adrenals. In: Clinical Endocrinology of Dogs and Cats. Hannover, Germany:Schlutersche; 2010, 93-154.Search in Google Scholar

2. Galac S, Kars VJ, Voorhout G, Mol JA, Kooistra HS. ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: A case report. Vet J 2008,177:141-143.10.1016/j.tvjl.2007.04.008Search in Google Scholar

3. Galac S, Kooistra HS, Voorhout G, van den Ingh TS, Mol JA, van den Berg G, Meij BP. Hyperadrenocorticism in a dog due to ectopic secretion of adrenocorticotropic hormone. Domest Anim Endocrinol 2005,28:338-348.10.1016/j.domaniend.2004.11.001Search in Google Scholar

4. Boujon, CE. Ritz, U. Rossi, GL. Bestetti, GE. A clinic-pathological study of canine Cushing's disease caused by pituitary carcinoma. J Comp Path 1991,105:353-365.10.1016/S0021-9975(08)80203-4Search in Google Scholar

5. Labelle P, Kyles E, Farver TB, de Cock HEV. Indicators of malignancy of canine adrenocortical tumors: Histopathology and proliferation index. Vet Pathol 2004,41:490-497.10.1354/vp.41-5-490Search in Google Scholar

6. Kooistra HS, Galac S. Recent advances in the diagnosis of cushing's syndrome in dogs. Vet Clin North Am Small Anim Pract 2010,40:259-267.10.1016/j.cvsm.2009.10.002Search in Google Scholar

7. Behrend EN, Kooistra HS, Nelson R, Reusch CE, Scott-Moncrieff JC. Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal]. J Vet Intern Med 2013,27:1292-1304.10.1111/jvim.12192Search in Google Scholar

8. Gilor C, Graves TK. Interpretation of laboratory tests for canine cushing's syndrome. Top Companion Anim Med. 2011,26:98-108.10.1053/j.tcam.2011.03.001Search in Google Scholar

9. van Vonderen IK, Kooistra HS, Rijnberk A. Influence of veterinary care on the urinary corticoid:Creatinine ratio in dogs. J Vet Intern Med 1998,12:431-435.10.1111/j.1939-1676.1998.tb02146.xSearch in Google Scholar

10. Galac S, Buijtels JJ, Kooistra HS. Urinary corticoid: Creatinine ratios in dogs with pituitary-dependent hypercortisolism during trilostane treatment. J Vet Intern Med 2009,23:1214-1219.10.1111/j.1939-1676.2009.0374.xSearch in Google Scholar

11. Kintzer PP, Peterson ME. Primary and secondary canine hypoadrenocorticism. Vet Clin North Am Small Anim Pract 1997,27:349-357.10.1016/S0195-5616(97)50036-2Search in Google Scholar

12. Ramsey IK. Trilostane in dogs. Vet Clin North Am Small Anim Pract 2010,40:269-283.10.1016/j.cvsm.2009.10.00820219488Search in Google Scholar

13. Auriemma E, Barthez PY, van der Vlugt-Meijer RH, Voorhout G, Meij BP. Computed tomography and low-field magnetic resonance imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism: 11 cases (2001-2003). J Am Vet Med Assoc 2009,15:409-414.10.2460/javma.235.4.40919681723Search in Google Scholar

14. van der Vlugt-Meijer RH, Meij BP, Voorhout G. Intraobserver and interobserver agreement, reproducibility, and accuracy of computed tomographic measurements of pituitary gland dimensions in healthy dogs. Am J Vet Res 2006,67:1750-1755.10.2460/ajvr.67.10.175017014327Search in Google Scholar

15. van der Vlugt-Meijer RH, Meij BP, Voorhout G. Dynamic computed tomographic evaluation of the pituitary gland in healthy dogs. Am J Vet Res 2004,65:1518-1524.10.2460/ajvr.2004.65.151815566090Search in Google Scholar

16. Kooistra HS, Voorhout G, Mol JA, Rijnberk A. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol 1997,152:387-394.10.1677/joe.0.15203879071959Search in Google Scholar

17. van der Vlugt-Meijer RH, Meij BP, van den Ingh TS, Rijnberk A, Voorhout G. Dynamic computed tomography of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 2003,17:773-780.10.1111/j.1939-1676.2003.tb02514.x14658712Search in Google Scholar

18. van der Vlugt-Meijer RH, Meij BP, Voorhout G. Thin-slice three-dimensional gradient-echo magnetic resonance imaging of the pituitary gland in healthy dogs. Am J Vet Res 2006,67:1865-1872.10.2460/ajvr.67.11.186517078748Search in Google Scholar

19. Rodriguez Pineiro MI, de Fornel-Thibaud P, Benchekroun G, Garnier F, Maurey-Guenec C, Delisle F, et al. Use of computed tomography adrenal gland measurement for differentiating ACTH dependence from ACTH independence in 64 dogs with hyperadenocorticism. J Vet Intern Med 2011,25:1066-1074.10.1111/j.1939-1676.2011.0773.x21848965Search in Google Scholar

20. Bertolini G, Furlanello T, De Lorenzi D, Caldin M. Computed tomographic quantification of canine adrenal gland volume and attenuation. Vet Radiol Ultrasound 2006,47:444-448.10.1111/j.1740-8261.2006.00164.x17009504Search in Google Scholar

21. Bertolini G, Furlanello T, Drigo M, Caldin M. Computed tomographic adrenal gland quantification in canine adrenocorticotroph hormone-dependent hyperadrenocorticism. Vet Radiol Ultrasound 2008,49:449-453.10.1111/j.1740-8261.2008.00405.x18833952Search in Google Scholar

22. Mogicato G, Layssol-Lamour C, Conchou F, Diquelou A, Raharison F, Sautet J, Concordet D. Ultrasonographic evaluation of the adrenal glands in healthy dogs: Repeatability, reproducibility, observer-dependent variability, and the effect of bodyweight, age and sex. Vet Rec 2011,168:130-134.10.1136/vr.c495021493488Search in Google Scholar

23. Barthez PY, Nyland TG, Feldman EC. Ultrasonographic evaluation of the adrenal glands in dogs. J Am Vet Med Assoc 1995,1:1180-1183.Search in Google Scholar

24. Choi J, Kim H, Yoon J. Ultrasonographic adrenal gland measurements in clinically normal small breed dogs and comparison with pituitary-dependent hyperadrenocorticism. J Vet Med Sci. 2011,73:985-959.10.1292/jvms.10-047921467755Search in Google Scholar

25. Benchekroun G, de Fornel-Thibaud P, Rodriguez Pineiro MI, Rault D, Besso J, Cohen A, et al. Ultrasonography criteria for differentiating ACTH dependency from ACTH independency in 47 dogs with hyperadrenocorticism and equivocal adrenal asymmetry. J Vet Intern Med2010,24:1077-1085.10.1111/j.1939-1676.2010.0559.x20666982Search in Google Scholar

26. Pey P, Vignoli M, Haers H, Duchateau L, Rossi F, Saunders JH. Contrast-enhanced ultrasonography of the normal canine adrenal gland. Vet Radiol Ultrasound. 2011,52:560-567.10.1111/j.1740-8261.2011.01823.x21521396Search in Google Scholar

27. Pey P, Rossi F, Vignoli M, Duchateau L, Marescaux L, Saunders JH. Use of contrastenhanced ultrasonography to characterize adrenal gland tumors in dogs. Am J Vet Res 2014, 75:886-892.10.2460/ajvr.75.10.88625255177Search in Google Scholar

28. Bargellini P, Orlandi R, Paloni C, Rubini G, Fonti P, Peterson ME, Boiti C. Contrast-enhanced ultrasonographic characteristics of adrenal glands in dogs with pituitary-dependent hyperadrenocorticism. Vet Radiol Ultrasound 2013,54:283-292.10.1111/vru.1201823441645Search in Google Scholar

29. Greco DS, Peterson ME, Davidson AP, Feldman EC, Komurek K. Concurrent pituitary and adrenal tumors in dogs with hyperadrenocorticism: 17 cases (1978-1995). J Am Vet Med Assoc 1999,214:1349-1353.Search in Google Scholar

30. Thuroczy J, van Sluijs FJ, Kooistra HS, Voorhout G, Mol JA, van der Linde-Sipman JS, Rijnberk A. Multiple endocrine neoplasias in a dog: Corticotrophic tumour, bilateral adrenocortical tumours, and pheochromocytoma. Vet Q 1998,20:56-61.10.1080/01652176.1998.96948399563161Search in Google Scholar

31. Meij BP, Voorhout G, van den Ingh TS, Hazewinkel HA, Teske E, Rijnberk A. Results of transsphenoidal hypophysectomy in 52 dogs with pituitary-dependent hyperadrenocorticism. Vet Surg 1998,27:246-261.10.1111/j.1532-950X.1998.tb00123.x9605236Search in Google Scholar

32. Hanson JM, van ‘t HM, Voorhout G, Teske E, Kooistra HS, Meij BP. Efficacy of transsphenoidal hypophysectomy in treatment of dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 2005,19:687-694.10.1111/j.1939-1676.2005.tb02747.xSearch in Google Scholar

33. Hanson JM, Teske E, Voorhout G, Galac S, Kooistra HS, Meij BP. Prognostic factors for outcome after transsphenoidal hypophysectomy in dogs with pituitary-dependent hyperadrenocorticism. J Neurosurg 2007,107:830-840.10.3171/JNS-07/10/083017937231Search in Google Scholar

34. Meij BP, Mol JA, van den Ingh TS, Bevers MM, Hazewinkel HA, Rijnberk A. Assessment of pituitary function after transsphenoidal hypophysectomy in beagle dogs. Domest Anim Endocrinol 1997, 14:81-97.10.1016/S0739-7240(96)00118-XSearch in Google Scholar

35. Meij BP. Hypophysectomy as a treatment for canine and feline Cushing's disease. Vet Clin North Am Small Anim Pract 2001, 31:1015-1041.10.1016/S0195-5616(01)50011-XSearch in Google Scholar

36. den Hertog E, Braakman JC, Teske E, Kooistra HS, Rijnberk A. Results of non-selective adrenocorticolysis by o,p’-DDD in 129 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec 1999,144:12-17.10.1136/vr.144.1.12Search in Google Scholar

37. Peterson ME, Kintzer PP. Medical treatment of pituitary-dependent hyperadrenocorticism. mitotane. Vet Clin North Am Small Anim Pract 1997,27:255-272.10.1016/S0195-5616(97)50030-1Search in Google Scholar

38. Rijnberk A, Belshaw BE. An alternative protocol for the medical management of canine pituitary-dependent hyperadrenocorticism. Vet Rec 1988,122:486-488.10.1136/vr.122.20.486Search in Google Scholar

39. Kintzer PP, Peterson ME. Diagnosis and management of canine cortisol-secreting adrenal tumors. Vet Clin North Am Small Anim Pract 1997,27:299-307.10.1016/S0195-5616(97)50033-7Search in Google Scholar

40. Neiger R, Ramsey I, O'Connor J, Hurley KJ, Mooney CT. Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec 2002,150:799-804.10.1136/vr.150.26.79912120922Search in Google Scholar

41. Witt AL, Neiger R. Adrenocorticotropic hormone levels in dogs with pituitary-dependent hyperadrenocorticism following trilostane therapy. Vet Rec 2004,154:399-400.10.1136/vr.154.13.39915083974Search in Google Scholar

42. Galac S, Buijtels JJ, Mol JA, Kooistra HS. Effects of trilostane on the pituitary-adrenocortical and renin-aldosterone axis in dogs with pituitary-dependent hypercortisolism. Vet J 2010,183:75-80.10.1016/j.tvjl.2008.10.00719042143Search in Google Scholar

43. Sieber-Ruckstuhl NS, Boretti FS, Wenger M, Maser-Gluth C, Reusch CE. Serum concentrations of cortisol and cortisone in healthy dogs and dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Vet Rec 2008,163:477-481.10.1136/vr.163.16.47718931355Search in Google Scholar

44. Wenger M, Sieber-Ruckstuhl NS, Muller C, Reusch CE. Effect of trilostane on serum concentrations of aldosterone, cortisol, and potassium in dogs with pituitary-dependent hyperadrenocorticism. Am J Vet Res 2004,65:1245-1250.10.2460/ajvr.2004.65.124515478772Search in Google Scholar

45. Griebsch C, Lehnert C, Williams GJ, Failing K, Neiger R. Effect of trilostane on hormone and serum electrolyte concentrations in dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 2014,28:160-165.10.1111/jvim.12268489553824341822Search in Google Scholar

46. Ruckstuhl NS, Nett CS, Reusch CE. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Am J Vet Res 2002,63:506-512.10.2460/ajvr.2002.63.50611939311Search in Google Scholar

47. Chapman PS, Kelly DF, Archer J, Brockman DJ, Neiger R. Adrenal necrosis in a dog receiving trilostane for the treatment of hyperadrenocorticism. J Small Anim Pract 2004, 45:307-310.10.1111/j.1748-5827.2004.tb00241.x15206477Search in Google Scholar

48. Ramsey IK, Richardson J, Lenard Z, Tebb AJ, Irwin PJ. Persistent isolated hypocortisolism following brief treatment with trilostane. Aust Vet J 2008,86:491-495.10.1111/j.1751-0813.2008.00373.x19076773Search in Google Scholar

49. Burkhardt WA, Guscetti F, Boretti FS, Ivos Todesco A, Aldajarov N, Lutz TA, Reusch CE, Siber-Ruckstuhl NS. Adrenocorticotropic hormone, but not trilostane, causes severe adrenal hemorrhage, vacuolization, and apoptosis in rats. Domest Anim Endocrinol 2011,40:155-164.10.1016/j.domaniend.2010.10.00221194873Search in Google Scholar

50. Teshima T, Matsumoto H, Kumagai T, Kurano M, Koyama H. Expression of 11beta-hydroxysteroid dehydrogenase isoforms in canine adrenal glands treated with trilostane. Vet J 2014,200:452-455.10.1016/j.tvjl.2014.03.02224745768Search in Google Scholar

51. Arenas C, Melian C, Perez-Alenza MD. Evaluation of 2 trilostane protocols for the treatment of canine pituitary-dependent hyperadrenocorticism: Twice daily versus once daily. J Vet Intern Med 2013,27:1478-1485.10.1111/jvim.1220724118316Search in Google Scholar

52. Augusto M, Burden A, Neiger R, Ramsey IK. A comparison of once and twice daily administration of trilostane to dogs with hyperadrenocorticism. Tierarztl Prax Ausg Kleintiere Heimtiere 2012,40:415-424.10.1055/s-0038-1623672Search in Google Scholar

53. Vaughan MA, Feldman EC, Hoar BR, Nelson RW. Evaluation of twice-daily, low-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism. J Am Vet Med Assoc 2008,232:1321-1328.10.2460/javma.232.9.132118447776Search in Google Scholar

54. Feldman EC. Evaluation of twice-daily lower-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism. J Am Vet Med Assoc 2011,238:1441-1451.10.2460/javma.238.11.144121627507Search in Google Scholar

55. Barker EN, Campbell S, Tebb AJ, Neiger R, Herrtage ME, Reid SW, Ramsey IK. A comparison of the survival times of dogs treated with mitotane or trilostane for pituitarydependent hyperadrenocorticism. J Vet Intern Med 2005,19:810-815.10.1111/j.1939-1676.2005.tb02769.xSearch in Google Scholar

56. Clemente M, De Andres PJ, Arenas C, Melian C, Morales M, Perez-Alenza MD. Comparison of non-selective adrenocorticolysis with mitotane or trilostane for the treatment of dogs with pituitary-dependent hyperadrenocorticism. Vet Rec 2007,161:805-809.Search in Google Scholar

57. Theon AP, Feldman EC. Megavoltage irradiation of pituitary macrotumors in dogs with neurologic signs. J Am Vet Med Assoc 1998,213:225-231.Search in Google Scholar

58. Goossens MM, Feldman EC, Theon AP, Koblik PD. Efficacy of cobalt 60 radiotherapy in dogs with pituitary-dependent hyperadrenocorticism. J Am Vet Med Assoc 1998,212:374-376.Search in Google Scholar

59. de Fornel P, Delisle F, Devauchelle P, Rosenberg D. Effects of radiotherapy on pituitary corticotroph macrotumors in dogs: A retrospective study of 12 cases. Can Vet J 2007, 48:481-486.Search in Google Scholar

60. Kent MS, Bommarito D, Feldman E, Theon AP. Survival, neurologic response, and prognostic factors in dogs with pituitary masses treated with radiation therapy and untreated dogs. J Vet Intern Med 2007,21:1027-1033.10.1111/j.1939-1676.2007.tb03060.xSearch in Google Scholar

61. Massari F, Nicoli S, Romanelli G, Buracco P, Zini E. Adrenalectomy in dogs with adrenal gland tumors: 52 cases (2002-2008). J Am Vet Med Assoc 2011,239:216-221.10.2460/javma.239.2.21621756177Search in Google Scholar

62. Schwartz P, Kovak JR, Koprowski A, Ludwig LL, Monette S, Bergman PJ. Evaluation of prognostic factors in the surgical treatment of adrenal gland tumors in dogs: 41 cases (1999-2005). J Am Vet Med Assoc 2008,232:77-84.10.2460/javma.232.1.7718167113Search in Google Scholar

63. Kyles AE, Feldman EC, De Cock HE, Kass PH, Mathews KG, Hardie EM, et al. Surgical management of adrenal gland tumors with and without associated tumor thrombi in dogs: 40 cases (1994-2001). J Am Vet Med Assoc 2003,223:654-662.10.2460/javma.2003.223.65412959384Search in Google Scholar

64. van Sluijs FJ, Sjollema BE, Voorhout G, van den Ingh TS, Rijnberk A. Results of adrenalectomy in 36 dogs with hyperadrenocorticism caused by adreno-cortical tumour. Vet Q. 1995,17:113-116.10.1080/01652176.1995.96945478525598Search in Google Scholar

65. Jimenez Pelaez M, Bouvy BM, Dupre GP. Laparoscopic adrenalectomy for treatment of unilateral adrenocortical carcinomas: Technique, complications, and results in seven dogs. Vet Surg 2008,37:444-453.10.1111/j.1532-950X.2008.00410.x18986311Search in Google Scholar

66. Naan EC, Kirpensteijn J, Dupre GP, Galac S, Radlinsky MG. Innovative approach to laparoscopic adrenalectomy for treatment of unilateral adrenal gland tumors in dogs. Vet Surg. 2013,6:710-715.10.1111/j.1532-950X.2013.12029.x23845023Search in Google Scholar

67. Eastwood JM, Elwood CM, Hurley KJ. Trilostane treatment of a dog with functional adrenocortical neoplasia. J Small Anim Pract 2003,44:126-131.10.1111/j.1748-5827.2003.tb00133.x12653328Search in Google Scholar

68. Benchekroun G, de Fornel-Thibaud P, Lafarge S, Gomez E, Begon D, Delisle F, Moraillon R, Heripret D, Maurey C, Rosenberg D. Trilostane therapy for hyperadrenocorticism in three dogs with adrenocortical metastasis. Vet Rec 2008,163:190-192.10.1136/vr.163.6.19018689782Search in Google Scholar

69. Helm JR, McLauchlan G, Boden LA, Frowde PE, Collings AJ, Tebb AJ, Elwood CM, Herrtage ME, Parkin TD, Ramsey IK. A comparison of factors that influence survival in dogs with adrenal-dependent hyperadrenocorticism treated with mitotane or trilostane. J Vet Intern Med 2011,25:251-60.10.1111/j.1939-1676.2011.0696.x21352377Search in Google Scholar

70. Arenas C, Perez-Alenza D, Melian C. Clinical features, outcome and prognostic factors in dogs diagnosed with non-cortisol-secreting adrenal tumours without adrenalectomy: 20 cases (1994-2009]. Vet Rec2013,173:501-504.10.1136/vr.10169124145503Search in Google Scholar